Mirum Pharmaceuticals (MIRM) Leases (2020 - 2025)
Mirum Pharmaceuticals (MIRM) has 6 years of Leases data on record, last reported at $8.7 million in Q4 2025.
- For Q4 2025, Leases rose 0.76% year-over-year to $8.7 million; the TTM value through Dec 2025 reached $8.7 million, up 0.76%, while the annual FY2025 figure was $8.7 million, 0.76% up from the prior year.
- Leases reached $8.7 million in Q4 2025 per MIRM's latest filing, up from $8.5 million in the prior quarter.
- Across five years, Leases topped out at $9.1 million in Q3 2024 and bottomed at $300000.0 in Q2 2022.
- Average Leases over 5 years is $3.9 million, with a median of $1.6 million recorded in 2021.
- Peak YoY movement for Leases: plummeted 82.94% in 2022, then surged 1026.91% in 2025.
- A 5-year view of Leases shows it stood at $1.6 million in 2021, then decreased by 8.8% to $1.4 million in 2022, then fell by 10.27% to $1.3 million in 2023, then skyrocketed by 575.62% to $8.7 million in 2024, then rose by 0.76% to $8.7 million in 2025.
- Per Business Quant database, its latest 3 readings for Leases were $8.7 million in Q4 2025, $8.5 million in Q3 2025, and $8.9 million in Q2 2025.